Paul Zintl

CEO, Partners in Health

Paul Zintl is Chief Operating Officer for Partners In Health (PIH) and Senior Advisor for Planning and Finance for the Program in Infectious Disease and Social Change (PIDSC) at Harvard Medical School (HMS). He is also currently serving as the chair of the Drug Management Sub-Committee within the Stop TB Partnership.

Prior to joining PIH/HMS, Mr. Zintl was a managing director of J.P. Morgan & Co. in New York, where he worked for 18 years, until 1995. In this capacity, his responsibilities included management, control, analysis, and evaluation of the firm's trading businesses. After leaving J.P. Morgan, he studied state criminal justice systems and worked as a private consultant for two years.

In 1998 he received a Master in Public Administration degree from the John F. Kennedy School of Government at Harvard.

Paul Zintl is Chief Operating Officer for Partners In Health (PIH) and Senior Advisor for Planning and Finance for the Program in Infectious Disease and Social Change (PIDSC) at Harvard Medical School (HMS). He is also currently serving as the chair of the Drug Management Sub-Committee within the Stop TB Partnership.

Prior to joining PIH/HMS, Mr. Zintl was a managing director of J.P. Morgan & Co. in New York, where he worked for 18 years, until 1995. In this capacity, his responsibilities included management, control, analysis, and evaluation of the firm's trading businesses. After leaving J.P. Morgan, he studied state criminal justice systems and worked as a private consultant for two years.

In 1998 he received a Master in Public Administration degree from the John F. Kennedy School of Government at Harvard.

Website
www.ghdonline.org